Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Net Income towards Common Stockholders (2012 - 2026)

Iqvia Holdings' (IQV) quarterly Net Income towards Common Stockholders came in at $241.0 million in Q2 2026, down 9.74% year-over-year from $267.0 million in Q2 2025, and down 10.41% quarter-over-quarter from $269.0 million in Q1 2026.

Analysis

Iqvia Holdings (IQV) Net Income towards Common Stockholders (2012 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Net Income towards Common Stockholders across 15 years of filings, most recently posting $241.0 million for Q2 2026.

  • In Q2 2026, Net Income towards Common Stockholders fell 9.74% year-over-year to $241.0 million; the TTM figure through Jun 2026 stood at $1.3 billion (up 6.02% YoY), while the FY2025 annual figure was $1.3 billion, down 2.12% from the prior year.
  • Net Income towards Common Stockholders came in at $241.0 million for Q2 2026 at Iqvia Holdings, down from $269.0 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $478.0 million in Q4 2025 to a low of $227.0 million in Q4 2022.
  • Average Net Income towards Common Stockholders over 5 years is $315.4 million, with a median of $291.0 million recorded in 2023.
  • Year-over-year, Net Income towards Common Stockholders slipped 28.39% in 2022 and surged 109.25% in 2023.
  • Over 5 years, Net Income towards Common Stockholders stood at $227.0 million in 2022, then surged by 109.25% to $475.0 million in 2023, then retreated by 9.05% to $432.0 million in 2024, then climbed by 10.65% to $478.0 million in 2025, then slumped by 49.58% to $241.0 million in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $241.0 million in Q2 2026, $269.0 million in Q1 2026, and $478.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 241.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 121.36 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 198.40 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -760,000.00
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -13.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -46.71 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -426,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -4.28 Bn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -2.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 241.00 Mn
Mar 31, 2026 269.00 Mn
Dec 31, 2025 478.00 Mn
Sep 30, 2025 332.00 Mn
Jun 30, 2025 267.00 Mn
Mar 31, 2025 262.00 Mn
Dec 31, 2024 432.00 Mn
Sep 30, 2024 284.00 Mn
Jun 30, 2024 361.00 Mn
Mar 31, 2024 291.00 Mn
Dec 31, 2023 475.00 Mn
Sep 30, 2023 298.00 Mn
Jun 30, 2023 294.00 Mn
Mar 31, 2023 291.00 Mn
Dec 31, 2022 227.00 Mn
Sep 30, 2022 290.00 Mn
Jun 30, 2022 257.00 Mn
Mar 31, 2022 329.00 Mn
Dec 31, 2021 317.00 Mn
Sep 30, 2021 261.00 Mn